Cellebrite DI Ltd.CLBTNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank78
3Y CAGR-71.8%
5Y CAGR+9.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-71.8%/yr
Quarterly compound
5Y CAGR
+9.6%/yr
Recent deceleration
Percentile
P78
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 147.13% |
| Q3 2025 | 2.11% |
| Q2 2025 | 56.06% |
| Q1 2025 | -68.35% |
| Q4 2024 | 58.38% |
| Q3 2024 | 186.98% |
| Q2 2024 | 44.54% |
| Q1 2024 | -77.09% |
| Q4 2023 | 50.21% |
| Q3 2023 | 76.03% |
| Q2 2023 | 32.86% |
| Q1 2023 | -65.10% |
| Q4 2022 | 6528.60% |
| Q3 2022 | 86.35% |
| Q2 2022 | 61.35% |
| Q1 2022 | -135.37% |
| Q4 2021 | 470.22% |
| Q3 2021 | -157.72% |
| Q2 2021 | 11343.55% |
| Q1 2021 | -100.39% |
| Q4 2020 | 93.04% |
| Q3 2020 | -26.97% |
| Q2 2020 | 553.78% |
| Q1 2020 | 0.00% |